Personnel Information

写真a

FUJIKI Tamami


Job title

Graduate Student

Campus Career 【 display / non-display

  • 2014.04
    -
    2015.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Nephrology, Resident
  • 2014.04
    -
    2015.03
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Department of Internal Medicine, Nephrology, Resident
  • 2017.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Nephrology, Graduate Student
 

Published Papers & Misc 【 display / non-display

  • Tamami Fujiki, Fumiaki Ando, Kana Murakami, Kiyoshi Isobe, Takayasu Mori, Koichiro Susa, Naohiro Nomura, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida. Tolvaptan activates the Nrf2/HO-1 antioxidant pathway through PERK phosphorylation. Sci Rep. 2019.06; 9 (1): 9245. ( PubMed, DOI )

  • Fujiki Tamami, Hirasawa Suguru, Watanabe Seishi, Iwamoto Shunsuke, Ando Ryoichi. 極めて重篤なTAFRO症候群に対してステロイドなしのトシリズマブ治療が奏効した1例(Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome) CEN Case Reports. 2017.05; 6 (1): 105-110. ( ichushi )

Conference Activities & Talks 【 display / non-display

  • Fujiki T, Ando F, Mandai S, Isobe K, Susa K, Mori T, Nomura N, Sohara E, Rai T, Uchida S. Tolvaptan activates the Nrf2/HO-1 pathway through PERK phosphorylation. The 23nd International Joint Conference on Cardiovascular and Metabolic diseases 2019.12.14

  • Fujiki T, Ando F, Mandai S, Isobe K, Susa K, Mori T, Nomura N, Sohara E, Rai T, Uchida S.. Tolvaptan and Bardoxolone Methyl Synergistically Activate the Nrf2/HO-1 pathway.. ASN Kidney Week 2019 2019.11.08

  • Fujiki T, Ando F, Isobe K, Susa K, Mori T, Nomura N, Sahara E, Rai T, Uchida S. Tolvaptan activates the Nrf2/HO-1 pathway through PERK phosphorylation. The 62nd Annual Meeting of the Japanese Society of Nephrology 2019.06.22 Nagoya

  • Tamami Fujiki, Fumiaki Ando, Kiyoshi Isobe, Takayasu Mori, Koichiro Susa, Naohiro Nomura, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida. Tolvaptan activates Nrf2/HO-1 pathway through PERK phosphorylation. The 52nd Annual Meeting of American Society of Nephrology, Kidney Week 2018 2018.10.26 San Diego